Longboard Pharmaceuticals Statistics
Total Valuation
MAC has a market cap or net worth of $4.57 billion. The enterprise value is $9.86 billion.
Important Dates
The last earnings date was Monday, August 11, 2025, after market close.
| Earnings Date | Aug 11, 2025 |
| Ex-Dividend Date | Sep 9, 2025 |
Share Statistics
MAC has 263.63 million shares outstanding. The number of shares has increased by 11.30% in one year.
| Current Share Class | 252.75M |
| Shares Outstanding | 263.63M |
| Shares Change (YoY) | +11.30% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.26% |
| Owned by Institutions (%) | 100.81% |
| Float | 252.27M |
Valuation Ratios
| Price/FFO Ratio | 11.58 |
| Price/AFFO Ratio | n/a |
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 3.80 |
| Forward PS | 4.65 |
| PB Ratio | 1.71 |
| P/TBV Ratio | 1.92 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | 14.64 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 8.94 |
| EV / EBITDA | 15.83 |
| EV / EBIT | 34.98 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.30, with a Debt / Equity ratio of 2.02.
| Current Ratio | 0.30 |
| Quick Ratio | 0.22 |
| Debt / Equity | 2.02 |
| Debt / EBITDA | 8.48 |
| Debt / FCF | n/a |
| Interest Coverage | 1.05 |
Financial Efficiency
Return on equity (ROE) is -16.16% and return on invested capital (ROIC) is 2.31%.
| Return on Equity (ROE) | -16.16% |
| Return on Assets (ROA) | 2.13% |
| Return on Invested Capital (ROIC) | 2.31% |
| Return on Capital Employed (ROCE) | 3.74% |
| Revenue Per Employee | $1.79M |
| Profits Per Employee | -$667,667 |
| Employee Count | 616 |
| Asset Turnover | 0.13 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -1.34M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.12% in the last 52 weeks. The beta is 2.19, so MAC's price volatility has been higher than the market average.
| Beta (5Y) | 2.19 |
| 52-Week Price Change | +16.12% |
| 50-Day Moving Average | 16.48 |
| 200-Day Moving Average | 17.83 |
| Relative Strength Index (RSI) | 58.73 |
| Average Volume (20 Days) | 1,831,597 |
Short Selling Information
The latest short interest is 14.48 million, so 5.49% of the outstanding shares have been sold short.
| Short Interest | 14.48M |
| Short Previous Month | 14.50M |
| Short % of Shares Out | 5.49% |
| Short % of Float | 5.74% |
| Short Ratio (days to cover) | 9.18 |
Income Statement
In the last 12 months, MAC had revenue of $1.10 billion and -$411.28 million in losses. Loss per share was -$1.71.
| Revenue | 1.10B |
| Gross Profit | 646.47M |
| Operating Income | 281.74M |
| Pretax Income | -75.04M |
| Net Income | -411.28M |
| EBITDA | 622.44M |
| EBIT | 281.74M |
| Loss Per Share | -$1.71 |
Full Income StatementBalance Sheet
The company has $131.09 million in cash and $5.39 billion in debt, giving a net cash position of -$5.26 billion or -$19.95 per share.
| Cash & Cash Equivalents | 131.09M |
| Total Debt | 5.39B |
| Net Cash | -5.26B |
| Net Cash Per Share | -$19.95 |
| Equity (Book Value) | 2.66B |
| Book Value Per Share | 10.21 |
| Working Capital | -833.04M |
Full Balance SheetCash Flow
| Operating Cash Flow | 313.93M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 58.62%, with operating and profit margins of 25.55% and -37.22%.
| Gross Margin | 58.62% |
| Operating Margin | 25.55% |
| Pretax Margin | -38.61% |
| Profit Margin | -37.22% |
| EBITDA Margin | 56.44% |
| EBIT Margin | 25.55% |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $0.68, which amounts to a dividend yield of 3.92%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 3.92% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.30% |
| Shareholder Yield | -7.40% |
| Earnings Yield | -8.95% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for MAC is $18.95, which is 9.32% higher than the current price. The consensus rating is "Hold".
| Price Target | $18.95 |
| Price Target Difference | 9.32% |
| Analyst Consensus | Hold |
| Analyst Count | 12 |
| Revenue Growth Forecast (5Y) | 3.84% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
